DXP Enterprises, Inc., together with its subsidiaries, engages in distributing maintenance, repair, and operating (MRO) products, equipment, and services in the United States, Canada, and internationally.
FAIL · Does not pass the screen
132.87 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price132.87 USD at the 5 Nov 2026 close
Our value readUndervalued vs our fair value, as of 5 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.34, read 2026-11-04
Ethical does not pass the values gate
Price132.87 USD
Fair value176.60
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-28Read Distribution177.54-25.2% to today ✓Markdown gives way to Distribution first Distribution read since July
2026-10-21Read Markdown183.24-27.5% to today ✓Accumulation gives way to Markdown first Markdown read since October
2026-10-14Read Accumulation180.92-26.6% to today Markdown gives way to Accumulation
2026-10-02Read Markdown188.19-29.4% to today ✓Markup gives way to Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
DXP Enterprises, Inc. holds its Distribution at $132.87. Consolidating, no directional conviction, held for 7 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 7 days
Price at the screen
$132.87
Valuation
27.88 trailing · 20.68 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.01
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
53.62%
Below 33%
Interest-bearing debt is 53.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
41.62%
Below 49%
Money owed to the company is 41.6% of assets, under the 49% limit.
Pass
Revenue purity
0.18%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
DXP Enterprises,'s business is in a permissible area, but its interest-bearing debt is about 54% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DXPE's ethical verdict changes
Today DXPE does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 10% discount to our $176.60 fair value, 15.60% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 24.8% discount to the base estimate.
Where our models see it going: fair-value estimate $176.60, with a range of $162.00 to $203.09, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Industrial distributor priced above its fair value
Every factory floor that needs a seal, pump or bearing at short notice relies on a specialist like DXP to keep machines turning. Yet the shares trade 8 percent above our fair value with a forward multiple of 22 times earnings, despite revenue growth of only 10 percent and thin 4 percent profit margins. The business clears our ethical screen, but that alone does not justify stretching the valuation.
The return on equity reaches 18 percent, yet the moat remains unknown and two analysts offer no clear consensus. Industrial distribution tends to track the broader economy, so current earnings may already reflect peak demand rather than a durable advantage. Paying a premium for modest growth leaves little room for disappointment.
Risk sits in the cyclical exposure and limited pricing power that can compress margins when volumes fall. Currency moves and supply-chain shocks add further volatility. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
DXPE trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Distribution$158.38-11.8%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Distribution$179.49+2.9%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Distribution$174.46+0.0%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Distribution$174.46+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Distribution$174.46-1.0%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Distribution$176.29+0.0%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Distribution$176.29+12.8%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 12.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Distribution$156.26-12.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158.
2026-10-21Markdown · changed$183.24+1.3%Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
